SS-31 (elamipretide) 300mg vial (50mg/ml 6ml)

SS-31 (elamipretide) 300mg vial (50mg/ml 6ml)

Injectable • 50mg/ml • 1 count

$900.00

Form

Injectable

Strength

50mg/ml

Quantity

1100
SS-31 (Elamipretide) 300 mg Vial – 50 mg/mL, 6 mL is a synthetic mitochondria-targeting tetrapeptide (D-Arg-2’,6’-dimethylTyr-Lys-Phe-NH₂) designed for research into mitochondrial function, oxidative stress reduction, and cellular bioenergetics. SS-31 selectively localizes to the inner mitochondrial membrane, where it interacts with cardiolipin to stabilize mitochondrial structure, reduce reactive oxygen species (ROS) production, and improve ATP synthesis. This mechanism makes it a promising investigational compound for conditions associated with mitochondrial dysfunction, including neurodegenerative diseases, cardiovascular disorders, metabolic dysfunction, and age-related cellular decline. A 6 mL vial at 50 mg/mL contains a total of 300 mg of SS-31, intended for research or controlled experimental administration. The peptide is typically prepared under sterile conditions and stored under refrigeration to maintain stability. Preclinical studies demonstrate SS-31’s potential to improve mitochondrial efficiency, reduce oxidative damage, and enhance cellular energy metabolism: https://pubmed.ncbi.nlm.nih.gov/24981848/ Elamipretide’s effects on mitochondrial ROS and bioenergetics: https://pubmed.ncbi.nlm.nih.gov/28097845/